New User? Sign Up | Sign In

Insider Trading - Mulroy Michael H.

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

Insider Trading Transactions for Mulroy Michael H.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-09-25
Purchase
2017-09-27
2:04 pm
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
1,537 $3.251 $4,997 1,537
(Direct)
View
2017-10-25
Purchase
2017-10-27
4:00 pm
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
1,939 $2.55 $4,944 3,476
(Direct)
View
2017-11-27
Purchase
2017-11-29
4:01 pm
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
2,076 $2.41 $5,003 5,552
(Direct)
View
2017-12-26
Purchase
2017-12-28
7:41 pm
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
2,247 $2.22 $4,988 7,799
(Direct)
View
2018-01-25
Purchase
2018-01-26
4:01 pm
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
2,134 $2.343 $5,000 9,933
(Direct)
View
2018-02-26
Purchase
2018-02-28
4:21 pm
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
2,255 $2.2172 $5,000 12,188
(Direct)
View
2018-03-26
Purchase
2018-03-28
5:00 pm
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
2,839 $1.76 $4,997 81,541
(Direct)
View
2018-04-25
Purchase
2018-04-27
4:33 pm
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
3,752 $1.33 $4,990 85,293
(Direct)
View
2018-05-25
Purchase
2018-05-31
5:00 pm
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
3,153 $1.5857 $5,000 88,446
(Direct)
View
2018-06-25
Purchase
2018-06-27
07:03 am
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
3,067 $1.63 $4,999 91,513
(Direct)
View
2018-07-25
Purchase
2018-07-27
4:00 pm
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
2,950 $1.6949 $5,000 94,463
(Direct)
View
2018-08-27
Purchase
2018-08-29
08:02 am
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
3,141 $1.5918 $5,000 97,604
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-07-01
Option Award
2016-07-05
8:01 pm
N/A
2021-06-30
BIOTIME INC BTX Mulroy Michael H.
Director
20,000 $0 20,000
(Direct)
View
2017-06-26
Option Award
2017-06-28
4:02 pm
N/A
2027-06-26
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
800,000 $0 800,000
(Direct)
View
2017-07-01
Option Award
2017-07-05
7:46 pm
N/A
2022-06-30
BIOTIME INC BTX Mulroy Michael H.
Director
20,000 $0 20,000
(Direct)
View
2018-03-15
Option Award
2018-03-19
7:03 pm
N/A
N/A
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
94,872 $0 107,060
(Direct)
View
2018-03-15
Tax Withholding
2018-03-19
7:03 pm
N/A
N/A
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
28,358 $1.95 78,702
(Direct)
View
2018-03-15
Option Award
2018-03-19
7:03 pm
N/A
2028-03-14
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
200,000 $0 200,000
(Direct)
View
2018-07-01
Option Award
2018-07-03
6:22 pm
N/A
2023-06-30
BIOTIME INC BTX Mulroy Michael H.
Director
40,000 $0 40,000
(Direct)
View
2019-03-01
Option Award
2019-03-05
4:31 pm
N/A
N/A
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
252,606 $0 350,210
(Direct)
View
2019-03-01
Tax Withholding
2019-03-05
4:31 pm
N/A
N/A
Asterias Biotherapeutics Inc. AST Mulroy Michael H.
CEO
76,588 $0.95 273,622
(Direct)
View
2019-03-11
Option Award
2019-03-13
9:03 pm
N/A
2029-03-10
AgeX Therapeutics Inc. AGE Mulroy Michael H.
Director
65,000 $0 65,000
(Direct)
View
2019-03-08
Option Award
2019-03-15
4:49 pm
N/A
N/A
BIOTIME INC BTX Mulroy Michael H.
Director
194,271 $0 226,821
(Direct)
View
2019-07-01
Option Award
2019-07-03
9:12 pm
N/A
2029-06-30
BIOTIME INC BTX Mulroy Michael H.
Director
40,000 $0 40,000
(Direct)
View
2020-07-01
Option Award
2020-07-02
5:04 pm
N/A
2030-07-01
Lineage Cell Therapeutics Inc. LCTX Mulroy Michael H.
Director
40,000 $0 40,000
(Direct)
View